Moreover, therapy based on uPAR targeting CAR-T cells has been reported to eliminate uPAR-positive senescent cells and improve fibrosis, suggesting the potential for various CAR-T cell applications in the treatment of liver disease [156]. Here, PLAUR is linked to liver disorder.